Two Sigma Investments’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.56M Sell
126,076
-89,112
-41% -$2.38M ﹤0.01% 2292
2025
Q4
$5.97M Buy
215,188
+204,581
+1,929% +$4.93M 0.01% 1557
2025
Q3
$265K Buy
+10,607
New +$235K ﹤0.01% 3271
2024
Q1
Sell
-8,198
Closed -$230K 3294
2023
Q4
$230K Buy
+8,198
New +$166K ﹤0.01% 2778

Other funds holding PHVS

Two Sigma Investments's PHVS Position: Q1 2026 in Review

Two Sigma Investments reduced its Pharvaris (PHVS) stake by 41% in Q1 2026, selling an estimated $2.38M and leaving 126,076 shares worth $3.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2292.

Two Sigma Investments first reported a position in PHVS in Q4 2023 and has held it in 4 quarters since. The position peaked at $5.97M in Q4 2025. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

  • Two Sigma Investments held 126,076 shares of Pharvaris worth $3.56M as of Q1 2026.
  • Two Sigma Investments sold 89,112 Pharvaris shares in Q1 2026, an estimated $2.38M.
  • Pharvaris made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2292 holding.
  • Two Sigma Investments first reported a position in Pharvaris in Q4 2023 and has held it in 4 quarters since.
  • Two Sigma Investments's Pharvaris position peaked at $5.97M in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.